Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A HITTMAIR

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
In Vitro Cellular & Developmental Biology. Animal|February 18, 1998
A reliable system for the culture of human prostatic cellsM V Cronauer, I E Eder, A Hittmair, et al.
Histopathology|September 1, 1993
Immunohistochemically demonstrated metallothionein expression in malignant melanomaB Zelger, A Hittmair, M Schir, et al.
Molecular Endocrinology (Baltimore, Md.)|December 1, 1993
Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesteroneZ Culig, A Hobisch, M V Cronauer, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|January 1, 1993
[Proliferative activity and p53 expression in transitional cell carcinoma of the urinary bladder]F A Offner, G Schäfer, A Hittmair, et al.
Cancer Detection and Prevention|January 1, 1996
Activation of two mutant androgen receptors from human prostatic carcinoma by adrenal androgens and metabolic derivatives of testosteroneZ Culig, J Stober, A Gast, et al.
Cytokine|August 1, 1995
IL-6 secretion by human peritoneal mesothelial and ovarian cancer cellsF A Offner, P Obrist, S Stadlmann, et al.
The American Journal of Surgical Pathology|November 1, 1991
Chromogranin A and B in adenomas of the pituitary. An immunohistochemical study of 42 casesK W Schmid, M Kröll, A Hittmair, et al.
The Prostate|February 1, 1997
Human prostatic smooth muscle cells in culture: estradiol enhances expression of smooth muscle cell-specific markersJ Zhang, M W Hess, M Thurnher, et al.
Urologia Internationalis|January 1, 1995
Androgen receptor alterations in patients with disturbances in male sexual development and in prostatic carcinomaH Klocker, F Neuschmid-Kaspar, Z Culig, et al.
British Journal of Cancer|September 25, 1999
Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model systemZ Culig, J Hoffmann, M Erdel, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
In Vitro Cellular & Developmental Biology. Animal|February 18, 1998
A reliable system for the culture of human prostatic cellsM V Cronauer, I E Eder, A Hittmair, et al.
Histopathology|September 1, 1993
Immunohistochemically demonstrated metallothionein expression in malignant melanomaB Zelger, A Hittmair, M Schir, et al.
Molecular Endocrinology (Baltimore, Md.)|December 1, 1993
Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesteroneZ Culig, A Hobisch, M V Cronauer, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|January 1, 1993
[Proliferative activity and p53 expression in transitional cell carcinoma of the urinary bladder]F A Offner, G Schäfer, A Hittmair, et al.
Cancer Detection and Prevention|January 1, 1996
Activation of two mutant androgen receptors from human prostatic carcinoma by adrenal androgens and metabolic derivatives of testosteroneZ Culig, J Stober, A Gast, et al.
Cytokine|August 1, 1995
IL-6 secretion by human peritoneal mesothelial and ovarian cancer cellsF A Offner, P Obrist, S Stadlmann, et al.
The American Journal of Surgical Pathology|November 1, 1991
Chromogranin A and B in adenomas of the pituitary. An immunohistochemical study of 42 casesK W Schmid, M Kröll, A Hittmair, et al.
The Prostate|February 1, 1997
Human prostatic smooth muscle cells in culture: estradiol enhances expression of smooth muscle cell-specific markersJ Zhang, M W Hess, M Thurnher, et al.
Urologia Internationalis|January 1, 1995
Androgen receptor alterations in patients with disturbances in male sexual development and in prostatic carcinomaH Klocker, F Neuschmid-Kaspar, Z Culig, et al.
British Journal of Cancer|September 25, 1999
Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model systemZ Culig, J Hoffmann, M Erdel, et al.
Pageof 10